|
|||||
|
|
Diminishing return for mechanistic therapeutics with neurodegenerative disease duration? |
|
| Authors: | David C Rubinsztein Harry T Orr |
| Institution: | 1. Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK;2. Institute for Translational Neuroscience, University of Minnesota, Minneapolis, MN, USA;3. Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA |
| Abstract: | |
| Keywords: | Huntington's disease neurodegeneration point of no return spinocerebellar ataxia type 1 therapy |